james-brey / iStockphoto.com

15 September 2017Americas

Dow asks SCOTUS to review $445m award dispute

Agriculture company Dow has asked the US Supreme Court to review a dispute centring on damages for infringement of patents related to genetically engineered soybeans.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

SCOTUS rejects Dow’s $455m appeal against Bayer

5 December 2017 The US Supreme Court has refused to rule on a patent dispute between agricultural companies Dow AgroSciences and Bayer CropScience.

Biosimilars Council urges SCOTUS to limit biologics exclusivity period

22 February 2017 The Biosimilars Council, a division of the Association for Accessible Medicines (AAM), has filed a brief in support of Sandoz’s petition for certiorari in the pending Sandoz v Amgen case.

AstraZeneca opposes Mylan’s request for SCOTUS hearing

25 November 2016 AstraZeneca and Acorda have asked the US Supreme Court not to hear an appeal from Mylan challenging a Federal Circuit ruling.

More on this story

SCOTUS rejects Dow’s $455m appeal against Bayer

5 December 2017 The US Supreme Court has refused to rule on a patent dispute between agricultural companies Dow AgroSciences and Bayer CropScience.

Biosimilars Council urges SCOTUS to limit biologics exclusivity period

22 February 2017 The Biosimilars Council, a division of the Association for Accessible Medicines (AAM), has filed a brief in support of Sandoz’s petition for certiorari in the pending Sandoz v Amgen case.

AstraZeneca opposes Mylan’s request for SCOTUS hearing

25 November 2016 AstraZeneca and Acorda have asked the US Supreme Court not to hear an appeal from Mylan challenging a Federal Circuit ruling.

More on this story

SCOTUS rejects Dow’s $455m appeal against Bayer

5 December 2017 The US Supreme Court has refused to rule on a patent dispute between agricultural companies Dow AgroSciences and Bayer CropScience.

Biosimilars Council urges SCOTUS to limit biologics exclusivity period

22 February 2017 The Biosimilars Council, a division of the Association for Accessible Medicines (AAM), has filed a brief in support of Sandoz’s petition for certiorari in the pending Sandoz v Amgen case.

AstraZeneca opposes Mylan’s request for SCOTUS hearing

25 November 2016 AstraZeneca and Acorda have asked the US Supreme Court not to hear an appeal from Mylan challenging a Federal Circuit ruling.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB